Yazdan Yazdanpanah
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 403 publications
Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines.
Journal: The New England journal of medicine
Published: July 22, 2026
Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
Andes hantavirus: operationalising science in real time.
Journal: Lancet (London, England)
Published: June 05, 2026
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines.
Journal: medRxiv : the preprint server for health sciences
Published: June 05, 2026
Soluble ST2 dynamics are associated with delayed hospital discharge in COVID-19 patients: a joint-modeling analysis of the DisCoVeRy trial's longitudinal data.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 01, 2026
Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness Agenda.
Journal: The Lancet regional health. Europe
Published: May 18, 2026
Beyond the Individual: The Weight of Social and Structural Determinants of Depression Among Transgender Women Living with HIV in France (ANRS-Trans&HIV).
Journal: AIDS and behavior
Published: May 11, 2026
Long Covid: how to prevent, treat and advance research?
Journal: Medecine sciences : M/S
Published: February 24, 2026
Overlooked risk factors for European autochthonous strongyloidiasis, Paris, France.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 23, 2026
Overlooked risk factors for European autochthonous strongyloidiasis, Paris, France.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 23, 2026
Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 22, 2026
Last Updated: 09/26/2026